Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pro-inflammatory cytokine and oxidative stress pathways represent a complex, interconnected network of biological processes rather than a single molecular target. These pathways involve the production and signaling of inflammatory mediators such as Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-6 (IL-6), alongside the generation of reactive oxygen species (ROS) that can damage cellular components. Chronic activation of these pathways is a hallmark of various pathologies, including rheumatoid arthritis, cardiovascular disease, and neurodegeneration. Therapeutic intervention typically focuses on specific nodes within these pathways, such as cytokine receptors or redox-sensitive transcription factors like NF-kappaB and Nrf2. Because this term encompasses a broad range of distinct proteins and mechanisms, it is classified as a pathway or biological process rather than a discrete therapeutic target.
Neutralization of circulating cytokines, blockade of cytokine receptors, inhibition of pro-inflammatory transcription factors, or induction of antioxidant enzymes via Nrf2 activation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-inflammatory cytokine and oxidative stress pathways.